Ligand Pharmaceuticals Inc., 10% Owner at Viking Therapeutics, Inc. (VKTX), sold 148,700 shares at $8.11 ($1.2M) on 2020-08-26, disclosed to the SEC on 2020-08-28.
Open-market sale of $1.2M VKTX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| Filing → |